CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,686 Cr | ₹2,177 Cr | ₹1,730 Cr | ₹1,364 Cr | ₹1,126 Cr |
What is the latest Total Liabilities ratio of CAPLIN POINT LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹2,686 Cr |
Mar2023 | ₹2,177 Cr |
Mar2022 | ₹1,730 Cr |
Mar2021 | ₹1,364 Cr |
Mar2020 | ₹1,126 Cr |
How is Total Liabilities of CAPLIN POINT LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,686 Cr | 23.34 | |
Mar2023 | ₹2,177 Cr | 25.85 | |
Mar2022 | ₹1,730 Cr | 26.88 | |
Mar2021 | ₹1,364 Cr | 21.13 | |
Mar2020 | ₹1,126 Cr | - |
Compare Total Liabilities of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹15,331.5 Cr | -4.7% | -4.8% | 38% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | -4.7% |
-4.8% |
38% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses